TUNIS, Jan. 30 (Xinhua) -- A first batch of 93,600 doses of the Pfizer-BioNTech COVID-19 vaccine will be acquired in mid-February and over 500,000 doses of Oxford-AstraZeneca vaccine will be provided at the end of February, Hechmi Louzir, director general of the Pasteur Institute of Tunis (IPT) announced Saturday.
"These doses are part of the international COVAX initiative," Louzir who is a member of Tunisian scientific committee for the fight against the coronavirus, specified in a statement to Tunis Afrique Presse (TAP).
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
